top of page

Diversified European cannabis cultivator, manufacturer, seller & distributor seeks strategic investor

A privately held, well established European cannabis company specializing in the cannabis value chain from seed to sale, including R&D, product formulation, manufacturing, B2B & B2C sales, distribution of cannabis raw materials, retail & branding

Listing ID:

10020205844

Licence(s) Held:

10020205844

Seeking €5 million investment to further expand its operations and capture greater market share across Europe and globally

Listing Details:

  • A vertically integrated, European cannabis company specializing in the cannabis value chain from seed to sale

  • Proven revenue ramp-up over the last 3 years. Generated over €11.5 million of sales revenue in 2021 with positive EBITDA

  • Currently undertaking research and innovation, product formulation, manufacturing, B-2-B international wholesale, sales and distribution of cannabis raw materials and derivative/finished products

  • Acquired 3,500 m2 facility with production capacity of up to 3.5 tons of high quality indoor flower per year

  • Specialized in cannabis and hemp breeding, propagation and production. Compiled one of Europe’s largest seedbanks

  • Import and export of raw material and bulk flowers (1kg upwards)

  • GACP certification is pending on the cultivation facility

  • Plan to upgrade to medical THC production and acquire EU GMP certification for drying, packaging, storage & distribution in 2023

  • Currently also undertaking B-2-B, B-2-C sales and e-commerce, retail and branding

  • Company controls a portfolio of leading European cannabis/CBD brands and has an extremely loyal client base

  • Successful business operations and marketing structure, e-commerce infrastructure, target focused in health and wellness/medicinal customers

  • Company also has a legal physical CBD store and selling its own recognized brands and products via top-ranked e-commerce store

  • The goal is to continue to expand in central Europe and globally, providing differentiated brands, quality and affordability of cannabis-based products

  • Managed by a highly experienced & diversified team of industry leaders with an entrepreneurial mindset, and a proven track record within the industry

  • Has exclusive partnerships across the value chain, including excellent relationships with regulatory authorities

  • The company is seeking €5 mill investment to further expand its operations and capture greater market share

10020205844

Inquiry Form

Thanks for submitting! We have received your message and will get back to you within 24 hours. Until then, you can send an email to info@hydeadvisory.com

Contact-us-deal

NEW CANNABIS BUSINESSES FOR SALE

See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.

Cannabis New/Featured Business Listing - Merger & Acquisition

4281915746

10,000 ft.² fully built, leased, indoor licenced processor with rec sales in GTA, ON for 500k OBO!

Cannabis New/Featured Business Listing - Merger & Acquisition

Exceptional opportunity to acquire a leased, purpose-designed, 10,000 ft.² indoor licensed processing facility located in a multi-unit industrial complex, situated in Toronto

Cannabis New/Featured Business Listing - Merger & Acquisition

21593646903

Licensed craft cultivation and processing facility in W. Ontario for $200k OBO!

Cannabis New/Featured Business Listing - Merger & Acquisition

Opportunity to purchase a craft cultivator and processor, brand and 10,000 ft.² leased facility in W. Ontario.

Cannabis New/Featured Business Listing - Merger & Acquisition

32892289643

Profitable, veteran-focused virtual medical cannabis clinic in Canada for sale!

Cannabis New/Featured Business Listing - Merger & Acquisition

Canadian online wellness and telehealth platform delivering integrative medicine and cannabis-enabled care, with $3.6M annual revenue and $1.5M EBITDA — supported by national clinician coverage, VAC billing expertise, and a lean, 100% virtual model

bottom of page